Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

SUDOGEST 30 MG TABLET

Pseudoephedrine Hydrochloride
$0.0763per EA
Low Outlier
OTC

Strength

30 mg/1

Manufacturer

Major Pharmaceuticals

NDC

00904672760

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

PSEUDOEPHEDRINE HYDROCHLORIDE

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

1/31/2019

Pharmacological Classes

Adrenergic alpha-Agonists
alpha-Adrenergic Agonist

Price History

1W

0.0%

1M

+5.1%

3M

+19.1%

6M

+24.2%

1Y

+24.1%

3Y

+51.7%

5Y

+61.2%

All

+41.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

RYNEX PSE LIQUID
Generic
00485020616•Edwards Pharmaceuticals, Inc.
$0.0364
per ML
SUDOGEST COLD AND ALLERGY TAB
Generic
00904535124•Major Pharmaceuticals
$0.0535
per EA
NASAL DECONGESTANT 30 MG TAB
Generic
36800043262•Topco Associates LLC
$0.0539
per EA
NASAL DECONGESTANT 30 MG TAB
Generic
36800043267•Topco Associates LLC
$0.0539
per EA
QC NASAL DECONGEST 30 MG TAB
Generic
63868080248•Chain Drug Marketing Association
$0.0553
per EA
LOHIST-D LIQUID
Generic
68047012016•Larken Laboratories, Inc.
$0.0587
per ML
SM NASAL DECONGEST 30 MG TAB
Generic
70677000501•Strategic Sourcing Services LLC
$0.0598
per EA
APRODINE TABLET
Generic
00904730224•Major Pharmaceuticals
$0.0611
per EA
APRODINE TABLET
Generic
00904730260•Major Pharmaceuticals
$0.0611
per EA
SM NASAL DECONGEST 30 MG TAB
Generic
70677000502•Strategic Sourcing Services LLC
$0.0641
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy